Case Report
Can COVID-19 Cause Flare-Ups of Acute Hepatitis B? An Atypical Presentation of COVID-19 with Acute Hepatitis B
Table 1
Clinical laboratory results on days 0, 3, and 6 of treatment.
| Item | Day 0 | Day 3 | Day 6 | Reference range |
| Body temperature (°C) | 39.4 | 36 | 39.9 | 36.1–37.0 | Pulse (beats/min) | 134 | 85 | 96 | 60–100 | Respiratory rate (breaths/min) | 27 | MV | MV | 12–20 | Blood pressure (mmHg) | 126/84 | 136/85 | 150/93 | 90–140/60–90 | Hemoglobin (g/dL) | 13.9 | 9.1 | 9.8 | 13–17 | White blood cell (×103/μL) | 10 | 8.1 | 10.1 | 04–10 | Neutrophil (%) | 78 | 56.5 | 60 | 50–75 | Absolute neutrophil (×103/μL) | 8 | 4.6 | 6.1 | 2.0–7.5 | Lymphocyte (%) | 14 | 26.3 | 16 | 20–40 | Absolute lymphocyte (×103/μL) | 1.4 | 2.1 | 1.6 | 0.8–4.0 | Platelets (×103/μL) | 64 | 32 | 39 | 150–400 | C-reactive protein (mg/L) | 67.4 | 11.8 | <5 | 0–10 | Procalcitonin (ng/mL) | 0.8 | 0.81 | 0.71 | 0–0.5 | Lactate (mmol/L) | 22.8 | 7 | 6.7 | 0.36–1.6 | pH value | 7.14 | 7.5 | 7.53 | 7.350–7.450 | Oxygen saturation (%) | 98 | 100 | 100 | 94–100 | Bicarbonate (mmol/L) | 7.4 | 25 | 25 | 22–29 | Alanine aminotransferase (U/L) | >7000 | 1089 | 188 | 0–40 | Aspartate aminotransferase (U/L) | >7000 | 526 | 98 | 0–41 | Total bilirubin (μmol/L) | 115 | 134 | 210 | 0–21 | Direct bilirubin (μmol/L) | 66 | 49.4 | 65.5 | 0–5 | Alkaline phosphatase (U/L) | 174 | 139 | 132 | 40–129 | Creatinine (μmol/L) | 305 | 635 | 568 | 62–106 | Glucose (mmol/L) | 3.2 | 8.5 | 13.7 | 3.9–6.1 | Ammonia (μmol/L) | 268 | 265 | 162 | 16–60 | D-Dimer (mg/L) | 11.5 | 8.7 | 33.18 | 0–0.5 | Fibrinogen (g/L) | 1.75 | 1.5 | 0.4 | 2–4.1 | INR | >10 | 7 | 2.2 | <1.1 | PT (seconds) | >120 | 84.1 | 26.6 | 9.4–12.5 | APTT (seconds) | 64 | 44.9 | 40.3 | 25.1–36.5 | Ferritin (μg/L) | 20573 | 2984 | 1447 | 38–270 | Ethanol | Negative | | | | Salicylate | Negative | | | | Blood culture and sensitivity | Negative | | Negative | | Hepatitis B core Ab | Reactive | | | | Hepatitis B core Ab IgM | Reactive | | | | Hepatitis B surface antigen | Reactive | | | | Hepatitis B surface Ab | Nonreactive | | | | Hepatitis B surface Ab Num. | <2.00 | | | | Hepatitis Be antigen | Reactive | | | | Hepatitis Be Ab | Nonreactive | | | | Hepatitis C Ab | Nonreactive | | | | Hepatitis B D Ab | Nonreactive | | | | Hepatitis total A Ab | Reactive | | | |
|
|